SIG & AnaBio: Joint innovation for pioneering solution

Long-life probiotics in aseptic packaging

Pioneering shelf-stable probiotic yogurt

SIG and AnaBio Technologies have jointly launched the world’s first long-life probiotic yogurt in aseptic packaging, creating a completely new category of shelf-stable probiotic beverages.

By combining AnaBio’s encapsulation technology with SIG’s gentle aseptic filling process, live probiotics can now survive heat treatment and remain stable without refrigeration. The result: nutritious probiotic drinks that stay fresh longer, reduce distribution costs, and expand access to health-focused products worldwide.

This breakthrough delivers convenient, sustainable, and high-quality probiotic beverages, meeting growing consumer demand for gut health and immunity support while enabling new opportunities across global markets.

Key features

The opportunities that arise from this groundbreaking innovation and partnership are manifold: including creating new product segments in emerging markets where highly nutritious products are urgently needed; to combining sustainable packaging solutions with healthy probiotic concepts previously only available in the fresh aisle.
  • No refrigeration needed – shelf-stable storage and easier distribution
  • Longer shelf life – reduces food waste and extends product availability
  • Live probiotics preserved – thanks to advanced encapsulation and aseptic filling
  • Health benefits – supports gut health and immunity
  • New product category – enables probiotic beverages beyond the chilled aisle
  • Global reach – ideal for markets with limited cold-chain infrastructure

AnaBio Technologies is a global leader in micro encapsulation technology. Micro encapsulation involves coating fragile bioactives in a protective coat at microscopic level enabling them to survive the stresses of processing, storage, and digestion. This unique technology makes it possible to deliver health benefits to consumers in a sustainable way and address some of the most pressing global health concerns, like immunity, obesity, and diabetes. Founded over 10 years ago as a university spin-out, AnaBio now operates from a 2000m2 Microencapsulation Centre of Excellence located outside Cork City in Ireland. AnaBio’s extensive IP portfolio is based on extensive functional and clinical trials and encompasses 13 patent families.